View Older Stories View More Recent Stories

Mar 13, 2024 07:54PM Form 4 Kymera Therapeutics, For: Mar 11 Filed by: Atlas Venture Associates Opportunity I, L.P.
Mar 13, 2024 04:56PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Mar 13, 2024 04:56PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Mar 13, 2024 07:00AM Novartis Acquires IFM Due to Develop First-In-Class STING Antagonist Program Targeting Innate Immune System
Mar 12, 2024 05:18PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Mar 12, 2024 05:03PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Mar 11, 2024 05:05PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Mar 11, 2024 05:02PM Form 144 Kymera Therapeutics, Filed by: Atlas Venture Opportunity Fund I, L.P.
Mar 6, 2024 07:00AM Sionna Therapeutics Announces $182 Million Series C Financing to Advance Clinical Development of Novel Small Molecules in Cystic Fibrosis
Mar 5, 2024 06:47PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Mar 5, 2024 06:46PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Mar 5, 2024 05:07PM Form 4 Dyne Therapeutics, Inc. For: Mar 01 Filed by: Atlas Venture Opportunity Fund II, L.P.
Mar 1, 2024 05:11PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Mar 1, 2024 05:08PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Feb 28, 2024 07:14PM Form 4 Dyne Therapeutics, Inc. For: Feb 26 Filed by: Atlas Venture Opportunity Fund II, L.P.
Feb 28, 2024 04:38PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Feb 27, 2024 05:24PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Feb 26, 2024 04:43PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Feb 23, 2024 06:59PM Form 4 Dyne Therapeutics, Inc. For: Feb 21 Filed by: Atlas Venture Opportunity Fund II, L.P.
Feb 23, 2024 05:29PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Feb 23, 2024 05:20PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Feb 23, 2024 05:19PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Feb 23, 2024 05:16PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Feb 20, 2024 06:36PM Form 4 Dyne Therapeutics, Inc. For: Feb 15 Filed by: Atlas Venture Associates XI, LLC
Feb 20, 2024 05:14PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Feb 15, 2024 05:29PM Form 144 Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Feb 9, 2024 04:33PM Form 4 Xilio Therapeutics, Inc. For: Feb 08 Filed by: Atlas Venture Associates XI, LLC
Feb 9, 2024 04:10PM Form SC 13G/A Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Feb 9, 2024 04:08PM Form SC 13G/A Day One Biopharmaceutica Filed by: Atlas Venture Fund XI, L.P.
Feb 9, 2024 04:06PM Form SC 13G/A Generation Bio Co. Filed by: Atlas Venture Fund X, L.P.
Feb 9, 2024 04:04PM Form SC 13G/A Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Feb 9, 2024 04:00PM Form 13F-HR Atlas Venture Life Scien For: Dec 31
Feb 7, 2024 07:00AM Arkuda Therapeutics Announces Option and Asset Purchase Agreement
Feb 2, 2024 10:21AM Form 13F-NT Atlas Venture Associates For: Dec 31
Feb 2, 2024 10:20AM Form 13F-NT Atlas Venture Fund VIII, For: Dec 31
Feb 2, 2024 10:19AM Form 13F-HR Atlas Venture Advisors, For: Dec 31
Feb 2, 2024 10:17AM Form 13F-NT Atlas Venture Associates For: Dec 31
Feb 1, 2024 09:00AM Be Biopharma to Present at the 20th Annual WORLDSymposium™ 2024
Jan 29, 2024 04:47PM Form 144 DraftKings Holdings Inc. Filed by: Atlas Venture Fund VIII, L.P.
Jan 25, 2024 04:39PM Form SC 13D/A Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Jan 25, 2024 04:32PM Form 4 Disc Medicine, Inc. For: Jan 23 Filed by: Atlas Venture Opportunity Fund II, L.P.
Jan 25, 2024 09:00AM Be Biopharma to Present at Keystone Symposia on Emerging Cellular Therapies
Jan 23, 2024 05:48PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund II, L.P.
Jan 23, 2024 05:47PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
Jan 23, 2024 05:45PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Jan 23, 2024 06:00AM Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies
Jan 17, 2024 06:00AM Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing to Advance Mission to Develop and Make Globally Available the First Treatment Targeting a Root Cause of Preeclampsia
Jan 16, 2024 06:16PM Form 4 Xilio Therapeutics, Inc. For: Jan 11 Filed by: Atlas Venture Associates XI, LLC
Jan 12, 2024 05:12PM Form 4 Disc Medicine, Inc. For: Jan 10 Filed by: Atlas Venture Associates Opportunity I, L.P.
Jan 10, 2024 09:52PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Opportunity Fund I, L.P.
View More Recent Stories View Older Stories